Precision BioSciences Inc
F:PBS0
Precision BioSciences Inc
F:PBS0
Price:
5.54
EUR
10.8%
Market Closed
Market Cap:
€126.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Precision BioSciences Inc
F:PBS0
|
US |
|
LuxExperience BV
F:0FV
|
DE |
|
J
|
J Sainsbury PLC
OTC:JSAIY
|
UK |
|
Prada SpA
F:PRP0
|
IT |
|
N
|
Navamedic ASA
OSE:NAVA
|
NO |
Income Statement
Earnings Waterfall
Precision BioSciences Inc
Precision BioSciences Inc
Income Statement
Precision BioSciences Inc
Precision BioSciences Inc
Currency: USD
| Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | Mar-2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
|
| Revenue |
7
N/A
|
11
+46%
|
15
+36%
|
18
+24%
|
21
+13%
|
22
+8%
|
24
+7%
|
19
-18%
|
22
+13%
|
24
+11%
|
34
+39%
|
101
+201%
|
118
+16%
|
116
-2%
|
102
-11%
|
38
-63%
|
21
-44%
|
25
+20%
|
31
+22%
|
47
+52%
|
52
+12%
|
49
-7%
|
58
+18%
|
88
+52%
|
75
-14%
|
69
-9%
|
51
-26%
|
1
-98%
|
1
-45%
|
34
+4 809%
|
45
+32%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||
| Operating Expenses |
(47)
|
(59)
|
(73)
|
(88)
|
(102)
|
(109)
|
(119)
|
(124)
|
(130)
|
(134)
|
(135)
|
(148)
|
(150)
|
(155)
|
(144)
|
(109)
|
(96)
|
(87)
|
(90)
|
(101)
|
(104)
|
(92)
|
(92)
|
(95)
|
(91)
|
(95)
|
(95)
|
(91)
|
(90)
|
(86)
|
(84)
|
|
| Selling, General & Administrative |
(11)
|
(14)
|
(16)
|
(19)
|
(23)
|
(27)
|
(32)
|
(34)
|
(35)
|
(36)
|
(36)
|
(37)
|
(38)
|
(40)
|
(41)
|
(41)
|
(42)
|
(41)
|
(42)
|
(41)
|
(41)
|
(39)
|
(36)
|
(35)
|
(34)
|
(35)
|
(35)
|
(36)
|
(35)
|
(32)
|
(30)
|
|
| R&D |
(35)
|
(43)
|
(56)
|
(67)
|
(76)
|
(78)
|
(82)
|
(83)
|
(88)
|
(91)
|
(91)
|
(103)
|
(104)
|
(108)
|
(102)
|
(68)
|
(55)
|
(42)
|
(34)
|
(44)
|
(49)
|
(49)
|
(52)
|
(56)
|
(54)
|
(57)
|
(58)
|
(54)
|
(54)
|
(54)
|
(53)
|
|
| Depreciation & Amortization |
0
|
(2)
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(7)
|
(6)
|
(5)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
0
|
(1)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
0
|
(11)
|
(11)
|
(11)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(39)
N/A
|
(48)
-22%
|
(58)
-21%
|
(70)
-20%
|
(81)
-16%
|
(87)
-7%
|
(95)
-9%
|
(104)
-9%
|
(108)
-4%
|
(110)
-1%
|
(101)
+8%
|
(47)
+54%
|
(32)
+31%
|
(39)
-23%
|
(42)
-7%
|
(72)
-71%
|
(75)
-4%
|
(62)
+17%
|
(59)
+5%
|
(54)
+9%
|
(52)
+4%
|
(44)
+16%
|
(35)
+21%
|
(7)
+79%
|
(16)
-122%
|
(26)
-61%
|
(44)
-69%
|
(90)
-104%
|
(90)
+1%
|
(52)
+42%
|
(39)
+25%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||
| Interest Income Expense |
1
|
2
|
(11)
|
(7)
|
(6)
|
(6)
|
7
|
3
|
2
|
1
|
0
|
0
|
0
|
3
|
2
|
0
|
(1)
|
0
|
1
|
2
|
3
|
2
|
5
|
6
|
7
|
4
|
4
|
1
|
(0)
|
(5)
|
(10)
|
|
| Non-Recurring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
18
|
22
|
30
|
18
|
11
|
7
|
11
|
5
|
|
| Pre-Tax Income |
(38)
N/A
|
(46)
-21%
|
(69)
-49%
|
(76)
-11%
|
(87)
-14%
|
(93)
-6%
|
(88)
+5%
|
(101)
-15%
|
(106)
-5%
|
(109)
-2%
|
(101)
+7%
|
(47)
+54%
|
(32)
+32%
|
(31)
+4%
|
(40)
-31%
|
(71)
-78%
|
(76)
-6%
|
(73)
+4%
|
(59)
+20%
|
(52)
+11%
|
(49)
+7%
|
(43)
+12%
|
(20)
+53%
|
16
N/A
|
11
-27%
|
7
-38%
|
(22)
N/A
|
(78)
-256%
|
(84)
-7%
|
(47)
+44%
|
(44)
+5%
|
|
| Net Income | ||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(38)
|
(46)
|
(69)
|
(76)
|
(87)
|
(93)
|
(88)
|
(101)
|
(106)
|
(109)
|
(101)
|
(47)
|
(32)
|
(31)
|
(40)
|
(71)
|
(76)
|
(73)
|
(59)
|
(52)
|
(49)
|
(43)
|
(20)
|
16
|
11
|
7
|
(22)
|
(78)
|
(84)
|
(47)
|
(44)
|
|
| Net Income |
(38)
N/A
|
(46)
-21%
|
(69)
-49%
|
(76)
-11%
|
(87)
-14%
|
(93)
-6%
|
(88)
+5%
|
(101)
-15%
|
(106)
-5%
|
(109)
-2%
|
(101)
+7%
|
(47)
+54%
|
(32)
+32%
|
(31)
+4%
|
(40)
-31%
|
(93)
-131%
|
(105)
-14%
|
(112)
-6%
|
(109)
+3%
|
(89)
+18%
|
(74)
+18%
|
(61)
+17%
|
(28)
+55%
|
17
N/A
|
9
-49%
|
7
-17%
|
(22)
N/A
|
(78)
-256%
|
(84)
-7%
|
(46)
+45%
|
(44)
+5%
|
|
| EPS (Diluted) |
-23.24
N/A
|
-28.17
-21%
|
-40.98
-45%
|
-45.81
-12%
|
-51.81
-13%
|
-66.36
-28%
|
-51.42
+23%
|
-58.49
-14%
|
-61.01
-4%
|
-62.86
-3%
|
-53.44
+15%
|
-23.3
+56%
|
-15.97
+31%
|
-15.64
+2%
|
-19.7
-26%
|
-21.24
-8%
|
-28.53
-34%
|
-38.1
-34%
|
-29.25
+23%
|
-22.59
+23%
|
-19.15
+15%
|
-15.96
+17%
|
-5.46
+66%
|
2.42
N/A
|
1.18
-51%
|
1.04
-12%
|
-2.36
N/A
|
-7.08
-200%
|
-7.07
+0%
|
-3.56
+50%
|
-1.76
+51%
|
|
Switch to:
Switch to:
See Also
Other Precision BioSciences Inc listings:
Discover More
